Showing results (161-170 of 176) with videos related to

Sort By:
Pageof 18
Elife|September 27, 2018
Sparse recurrent excitatory connectivity in the microcircuit of the adult mouse and human cortexStephanie C Seeman, Luke Campagnola, Pasha A Davoudian, et al.
The Lancet. Child & Adolescent Health|November 20, 2023
Vosoritide therapy in children with achondroplasia aged 3-59 months: a multinational, randomised, double-blind, placebo-controlled, phase 2 trialRavi Savarirayan, William R Wilcox, Paul Harmatz, et al.
The New England Journal of Medicine|November 18, 2024
Oral Infigratinib Therapy in Children with AchondroplasiaRavi Savarirayan, Josep Maria De Bergua, Paul Arundel, et al.
Hepatology Communications|February 19, 2025
Liver involvement in a large cohort of patients with erythropoietic protoporphyria or X-linked protoporphyriaCynthia Levy, Hetanshi Naik, Jessica Overbey, et al.
Therapeutic Advances in Musculoskeletal Disease|March 28, 2022
Infigratinib in children with achondroplasia: the PROPEL and PROPEL 2 studiesRavi Savarirayan, Josep Maria De Bergua, Paul Arundel, et al.
Nature Neuroscience|November 17, 2015
Canonical genetic signatures of the adult human brainMichael Hawrylycz, Jeremy A Miller, Vilas Menon, et al.
Journal of Neurointerventional Surgery|February 17, 2021
Upper extremity transvenous access for neuroendovascular procedures: an international multicenter case seriesIsaac Josh Abecassis, Vasu Saini, Timothy John Phillips, et al.
The New England Journal of Medicine|June 11, 2020
Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent PorphyriaManisha Balwani, Eliane Sardh, Paolo Ventura, et al.
The New England Journal of Medicine|June 29, 2026
Phase 3 Trial of Oral Infigratinib in Children with AchondroplasiaRavi Savarirayan, Julie Hoover-Fong, Melita Irving, et al.
Pageof 18